Cellink closes Skr3bn capital raising

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
Equity-Linked

Cellink closes Skr3bn capital raising

Aidan Gregory
March 12, 2021 11:00 am
Cellink_2_alamy_575_375
PWKB14 A Cellink technician is seen explaining to the visitors on the operation of the new bio printers during the event. Feria de Barcelona hosts the third edition of the (3D) industry week. The objective is to accelerate the use of technologies and industrial sectors such as Robotics, molds and matrices, new materials and 3D printing. | Alamy Stock Photo

Cellink, the Swedish developer of 3D printing equipment for living cells, rose in trading on Friday morning after the company completed a Skr3bn ($350m) sale of new shares and convertible bonds to finance its acquisition of MatTek Corporation in the United States.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

JP MorganNordicsSwedenHealth and BiotechEquityEuropeEMEASRIEquity-Linked
AG
Aidan Gregory
Gift this article